207 related articles for article (PubMed ID: 26433554)
1. The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers.
Schott AF; Welch JJ; Verschraegen CF; Kurzrock R
Semin Oncol; 2015 Oct; 42(5):731-9. PubMed ID: 26433554
[TBL] [Abstract][Full Text] [Related]
2. New clinical research strategies for rare gynecologic malignancies.
Ray-Coquard I; Pujade-Lauraine E; Ledermann JA
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):53-7. PubMed ID: 25490380
[TBL] [Abstract][Full Text] [Related]
3. The promise and challenges of rare cancer research.
Komatsubara KM; Carvajal RD
Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
[No Abstract] [Full Text] [Related]
4. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
5. Research methods to change clinical practice for patients with rare cancers.
Billingham L; Malottki K; Steven N
Lancet Oncol; 2016 Feb; 17(2):e70-e80. PubMed ID: 26868356
[TBL] [Abstract][Full Text] [Related]
6. Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications.
Unger JM; Nghiem VT; Hershman DL; Vaidya R; LeBlanc M; Blanke CD
JAMA Netw Open; 2019 Sep; 2(9):e1910593. PubMed ID: 31483471
[TBL] [Abstract][Full Text] [Related]
7. Rare cancers in children - The EXPeRT Initiative: a report from the European Cooperative Study Group on Pediatric Rare Tumors.
Bisogno G; Ferrari A; Bien E; Brecht IB; Brennan B; Cecchetto G; Godzinski J; Orbach D; Reguerre Y; Stachowicz-Stencel T; Schneider DT
Klin Padiatr; 2012 Oct; 224(6):416-20. PubMed ID: 23143769
[TBL] [Abstract][Full Text] [Related]
8. The Globalization of Cooperative Groups.
Valdivieso M; Corn BW; Dancey JE; Wickerham DL; Horvath LE; Perez EA; Urton A; Cronin WM; Field E; Lackey E; Blanke CD
Semin Oncol; 2015 Oct; 42(5):693-712. PubMed ID: 26433551
[TBL] [Abstract][Full Text] [Related]
9. Rare Tumors in Children: Progress Through Collaboration.
Pappo AS; Furman WL; Schultz KA; Ferrari A; Helman L; Krailo MD
J Clin Oncol; 2015 Sep; 33(27):3047-54. PubMed ID: 26304909
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challenges.
Ledermann JA; Ray-Coquard I
Am Soc Clin Oncol Educ Book; 2014; ():e282-6. PubMed ID: 24857114
[TBL] [Abstract][Full Text] [Related]
11. The value of research collaborations and consortia in rare cancers.
Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
[TBL] [Abstract][Full Text] [Related]
12. Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.
Bando H; Takebe N
Jpn J Clin Oncol; 2015 Nov; 45(11):1001-6. PubMed ID: 26423340
[TBL] [Abstract][Full Text] [Related]
13. Collaboration is key to treating uncommon cancers: scientists and patients champion research in these rare diseases.
Printz C
Cancer; 2010 Jun; 116(12):2847-9. PubMed ID: 20564387
[No Abstract] [Full Text] [Related]
14. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
Bogaerts J; Sydes MR; Keat N; McConnell A; Benson A; Ho A; Roth A; Fortpied C; Eng C; Peckitt C; Coens C; Pettaway C; Arnold D; Hall E; Marshall E; Sclafani F; Hatcher H; Earl H; Ray-Coquard I; Paul J; Blay JY; Whelan J; Panageas K; Wheatley K; Harrington K; Licitra L; Billingham L; Hensley M; McCabe M; Patel PM; Carvajal R; Wilson R; Glynne-Jones R; McWilliams R; Leyvraz S; Rao S; Nicholson S; Filiaci V; Negrouk A; Lacombe D; Dupont E; Pauporté I; Welch JJ; Law K; Trimble T; Seymour M
Eur J Cancer; 2015 Feb; 51(3):271-81. PubMed ID: 25542058
[TBL] [Abstract][Full Text] [Related]
15. Update on Enrollment of Older Adults Onto National Cancer Institute National Clinical Trials Network Trials.
Mishkin GE; Denicoff AM; Best AF; Little RF
J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):111-116. PubMed ID: 36519819
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial design for rare cancers: why a less conventional route may be required.
Panageas KS
Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies.
Weiss AR; Nichols CR; Freyer DR
Semin Oncol; 2015 Oct; 42(5):740-7. PubMed ID: 26433555
[TBL] [Abstract][Full Text] [Related]
18. The U.S. pediatric cancer clinical trials programmes: international implications and the way forward.
Bleyer WA
Eur J Cancer; 1997 Aug; 33(9):1439-47. PubMed ID: 9337687
[TBL] [Abstract][Full Text] [Related]
19. Preclinical rare cancer research to inform clinical trial design.
Barker HE; Scott CL
Nat Rev Cancer; 2019 Sep; 19(9):481-482. PubMed ID: 31263218
[No Abstract] [Full Text] [Related]
20. Cooperative Group Trials in the Community Setting.
Lloyd Wade J; Petrelli NJ; McCaskill-Stevens W
Semin Oncol; 2015 Oct; 42(5):686-92. PubMed ID: 26433550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
